News

EU4Health - Call for Proposals crisis preparedness

Published on | 1 year ago

Programmes Health

The Commission has published the call for proposals for EU action grants in the area of crisis preparedness, under the EU4Health Annual Work Programme 2024:

  1. EU4H-2024-PJ-01-1 (CP-g-24-10): Call for proposals on the European Hub for vaccine development (HERA)
  2. EU4H-2024-PJ-01-2 (CP-g-24-11): Call for proposals for next-generation respiratory protection (HERA)
  3. EU4H-2024-PJ-01-3 (CP-g-24-12): Call for proposals to support innovative manufacturing technologies and processes in the Union for medicines production (HERA)
  4. EU4H-2024-PJ-01-4 (CP-g-24-105): Call for proposals to support the development of novel antivirals (HERA)

Deadline for application is 5 September 2024, 17:00 CEST.

Source: Funding & Tenders Portal

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1782 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.